# Capricor Therapeutics, Inc.: Form 8-K, filed Mar 11, 2021

- Company: [Capricor Therapeutics, Inc.](/companies/capr.md) (CIK 1133869)
- Form: 8-K
- Filed: 2021-03-11
- Accepted by EDGAR: Mar 11, 2021, 16:01 ET
- Period: 2021-03-11
- Accession: 0001104659-21-034985
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1133869/000110465921034985/tm219445d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133869/000110465921034985/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133869/000110465921034985/tm219445d1_8k.htm

Filed Mar 11, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-034985. Last ingested by Listed: Nov 14, 2026, 18:39 ET. No prices; not investment advice.
